Concepedia

Stacey Stein

SS

Statistics

Publications

42

Citations

4.7K

H-Index

22

Active since

1998

Affiliations

Yale University(Current)

Yale Cancer Center

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

University of Michigan

Stacey Stein is an author at Yale University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1998–2024

42

Publications

42

Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2021 · 999 citations · Full text

, , +22

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

, , +5

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu et al. · The Lancet Oncology · 2020 · 555 citations

, , +8

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2017 · 345 citations · Full text

, , +17

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019

Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott et al. · Journal of the National Comprehensive Cancer Network · 2019 · 276 citations · Full text

1–5 of 42